Is EGRAY or JNJ a better dividend investment in 2026?

EGRAY currently yields 16393.44% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: EGRAY offers higher current income.

What is the dividend yield difference between EGRAY and JNJ?

EGRAY has a forward dividend yield of 16393.44% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 16390.08 percentage points.

Home › Compare › EGRAY vs JNJ

EGRAY vs JNJ: Dividend Comparison 2026

EGRAY yields 16393.44% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EGRAY wins by $7301536759432773632.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EGRAY

● Live price

16393.44%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7301536759432773632.00M

Annual income

$7,214,959,957,960,809,000,000,000.00

Full EGRAY calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — EGRAY vs JNJ

📍 EGRAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EGRAY	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EGRAY + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EGRAY pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EGRAY

Annual income on $10K today (after 15% tax)

$1,393,442.62/yr

After 10yr DRIP, annual income (after tax)

$6,132,715,964,266,687,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, EGRAY beats the other by $6,132,715,964,266,687,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EGRAY + JNJ for your $10,000?

EGRAY: 50%JNJ: 50%

100% JNJ50/50100% EGRAY

Portfolio after 10yr

$3650768379716386816.00M

Annual income

$3,607,479,978,980,404,400,000,000.00/yr

Blended yield

98.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EGRAY

No analyst data

Altman Z

-2.6

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EGRAY buys

JNJ buys

No recent congressional trades found for EGRAY or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEGRAYJNJ

Forward yield	16393.44% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$7301536759432773632.00M ✓	$20.0K
Annual income after 10y	$7,214,959,957,960,809,000,000,000.00 ✓	$827.78
Total dividends collected	$7295813577613468672.00M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EGRAY vs JNJ ($10,000, DRIP)

Year	EGRAY Portfolio	EGRAY Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$1,650,044	$1,639,344.26	$10,676	$355.77	+$1.64M → EGRAY
2	$254,568,407	$252,802,859.25	$11,407	$389.39	+$254.56M → EGRAY
3	$36,723,192,347	$36,450,804,151.57	$12,198	$426.53	+$36723.18M → EGRAY
4	$4,953,566,593,715	$4,914,272,777,904.21	$13,056	$467.62	+$4953566.58M → EGRAY
5	$624,817,076,403,443	$619,516,760,148,167.90	$13,987	$513.12	+$624817076.39M → EGRAY
6	$73,699,036,268,644,480	$73,030,481,996,892,780.00	$14,998	$563.56	+$73699036268.63M → EGRAY
7	$8,129,477,595,099,639,000	$8,050,619,626,292,188,000.00	$16,098	$619.52	+$8129477595099.62M → EGRAY
8	$838,637,897,420,996,700,000	$829,939,356,394,240,100,000.00	$17,295	$681.69	+$838637897420996.75M → EGRAY
9	$80,912,898,571,929,100,000,000	$80,015,556,021,688,630,000,000.00	$18,599	$750.82	+$80912898571929088.00M → EGRAY
10	$7,301,536,759,432,774,000,000,000	$7,214,959,957,960,809,000,000,000.00	$20,022	$827.78	+$7301536759432773632.00M → EGRAY

EGRAY vs JNJ: Complete Analysis 2026

EGRAY — Stock

Energy Resources of Australia Ltd operates as a uranium producer. It holds a 100% interest in the Jabiluka mineral lease. The company was incorporated in 1980 and is headquartered in Darwin, Australia. Energy Resources of Australia Ltd is a subsidiary of North Limited.

Full EGRAY Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this EGRAY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EGRAY vs SCHD EGRAY vs JEPI EGRAY vs O EGRAY vs KO EGRAY vs MAIN EGRAY vs ABBV EGRAY vs MRK EGRAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.